Company Search:
Advanced Search
Sponsored Links
CellSeed Incorporation Company Snapshot
CellSeed Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares CellSeed Incorporation with three other companies in this sector in Japan: Ribomic Inc (2016 sales of 121.91 million Japanese Yen [US$1.10 million] of which 100% was Physical Research), Healios Kk (77.64 million Japanese Yen [US$702,642.00 ] of which 100% was Pharmaceuticals Preparation), and Canbas Co Ltd (105.24 million Japanese Yen [US$952,449.15 ] ).

Sales Analysis. CellSeed Incorporation reported sales of ¥100.67 million (US$911.09 thousand) for the year ending December of 2016. This represents a sharp decrease of 47.9% versus 2015, when the company's sales were ¥193.12 million. Contributing to the drop in overall sales was the 55.6% decline in Cell Sheet Regenerative Medicine Busines, from ¥112.50 million to ¥50.00 million. There were also decreases in sales in Regenerative Medicine Business Support (down 37.1% to ¥50.67 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
CellSeed Incorporation
  Stock Performance Chart for CellSeed Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 533.00
(Figures in Japanese Yen)
1 Week 12.2%   13 Weeks 9.7%  
4 Weeks 9.7%   52 Weeks -2.4%  
CellSeed Incorporation Key Data:
  Ticker: 7776 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 100,673,000
(Year Ending Jan 2017).
Employees: 33
  Currency: Japanese Yen Market Cap: 5,870,617,636
  Fiscal Yr Ends: December Shares Outstanding: 11,014,292
  Share Type: Common Closely Held Shares: 1,165,100
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.